Table 1.
Patient Characteristics
Gout Patients | Comparator Patients | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Study | Design | Population | Dates | N | Disease duration, years (mean) |
Age, years (mean) |
N | Age, years (mean) |
Arthrocentesis | Conditions |
Ultrasound | ||||||||||
Ottaviani 2012 | Prospective Case-Control | Hospital outpatients with rheumatic disease | 11/2008–10/2010 | 53 | 9.2 | 59.7 | 50 | 59.5 | Yes | CPPD, RA, OA, PsA |
Lamers-Karnebeek 2014 | Prospective Cross-Sectional | Patients presenting with mono- or oligoarthritis | NR | 26 | NR | 63.5 | 28 | NR | Yes | CPPD, ReA, PsA, OA, PMR, UA, Lofgren’s Syndrome, Gout with neg MSU (2 patients) |
Thiele 2007 | Retrospective Case-Control | Rheumatology clinic patients with unclear diagnosis | 11/2003–12/2004 | 23 | NR | 58.6 | 23 | NR | No | CPPD, RA, sarcoidosis, OA, FMS, PsA, bursitis, tendinitis, Inflammatory oligoarthritis NOS, lateral epicondylitis, muscle fiber tear |
Naredo 2013 | Prospective Case-Control | Rheumatology and general practice clinics | NR | 91 | 7 | 56.4 | 42 | 56.6 | NR | RA, SpA, healthy |
Nalbant 2003 | Prospective Case-Control | Patients with subcutaneous nodules and rheumatic disease attending rheumatology clinics | 5/2001–10/2001 | 10 | 10.7 | 61.3 | 13 | 56.5 | NR | RA |
Ponce 2009† | Prospective Cross-Sectional | Patients with joint effusion | NR | 13 | NR | NR | 88 | NR | Yes | OA, RA, SpA, UIA, CTD, CPPD, bursitis, AVN, hemorrhagic joint |
Bergner 2013† | Cross-Sectional | Patients undergoing arthrocentesis | NR | 39 | NR | NR | 74 | NR | Yes | CPPD, Non-crystal arthropathy |
Dual Energy Computed Tomography | ||||||||||
Glazebrook 2011 | Retrospective Cross-sectional | Patients with arthralgia and potential gout | 4/2008–2/2010 | 12* | NR | NR | 19 | NR | Yes | CPPD, possible diagnoses of RA, seronegative IA, and CTS |
Bongartz 2014 | Prospective Case-Control | Patients with joint pain or swelling in rheumatology procedure clinic | 10/2010–9/2012 | 40 | NR** | 62.1 | 41 | 58.7 | Yes | OA, RA, septic arthritis, CTD, CPPD, unknown |
Choi 2012 | Prospective Case-Control | Clinic patients with arthritis | 12/2009–6/2011 | 40 | 13 | 62 | 40 | 53 | NR | RA, PsA, OA, UIA, AS |
Plain Radiography | ||||||||||
Parker 1984 | Retrospective Cross-sectional | Patients undergoing routine lateral CXR | 1978–1980 | 20 | NR | 60.8 | Healthy: 69 Arthritis: 88 |
Healthy: 52.6 Arthritis: 58 |
NR | Among those with arthritis: RA, ReA, AS, PsA, CPPD, PMR, DISH |
43 patients included in study initially but only 12 were found to have MSU crystals.
20 patients had symptom duration <6 weeks.
Refers to an abstract.
Abbreviations: NR=not reported, RA=Rheumatoid Arthritis, SpA=Spondyloarthropathy, ReA=Reactive Arthritis, AS=Ankylosing Spondylitis, PsA=Psoriatic Arthritis, OA=Osteoarthritis, UIA=Undifferentiated Inflammatory Arthritis, CPPD=Calcium Pyrophosphate Disease, PMR=Polymyalgia Rheumatica, DISH=Diffuse Idiopathic Skeletal Hyperostosis, AVN=Avascular Necrosis, CTD=Connective Tissue Disease, CXR=chest radiograph